{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:09:51Z","timestamp":1794506991554,"version":"4.9.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Butyric acid is a major gut microbiota metabolite that exhibits many biological functions, including the suppression of colorectal cancer (CRC) growth. However, previous studies have mainly been conducted using cell lines, which do not recapitulate the genuine three\u2212dimensional spatial characteristics of CRC. In this study, we explored the therapeutic outcome and precise molecular targets of butyrate with sodium butyrate (NaB) using tumor organoids of CRC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Firstly, we examined the influence of butyrate on CRC subcutaneous allografts. And then the biological effects of butyrate were mainly determined using CRC organoids derived from KPC mice and Caco-2 cells. The morphological characteristics of butyrate-treated CRC organoids were analyzed, and multiple experimental assays were employed to determine the biological and molecular influences of butyrate. Finally, the inhibitor of HDAC2 was used to mimic the biological effects of butyrate on CRC organoids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>It was observed that butyrate significantly suppressed the growth of CRC allografts. Importantly, butyrate could apparently inhibit the proliferation, disrupt epithelial integrity, and induce apoptosis in CRC organoids. Transcriptomic analyses revealed that butyrate acts as an epigenetic modulator, targeting HDAC2 and selectively repressing its transcription. This led to inhibition of cyclin D1, CDK4\/6, and upregulation of p21 expression, suggesting cell cycle arrest. The selective HDAC2 inhibitor similarly recapitulated the influences of butyrate on CRC organoids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Butyrate exerts the definitive blocking effects on cell cycle progression in CRC organoids, and HDAC2 is one of the important targets. Butyrate modulates cell cycle via targeting HDAC2, constituting a novel therapeutic pathway for CRC. This study provides new evidence for gut microbial metabolites as a potential means for the prevention and treatment of colorectal cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1788434","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:44:59Z","timestamp":1779169499000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Butyrate blocks cell cycle progression in colorectal cancer organoids partially through HDAC2 inhibition"],"prefix":"10.3389","volume":"17","author":[{"given":"Banghui","family":"Liu","sequence":"first","affiliation":[{"name":"North Sichuan Medical College","place":["Nanchong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Huang","sequence":"additional","affiliation":[{"name":"Precision Radiation in Oncology Key Laboratory of Sichuan Province, Department of Experimental Research, Sichuan Cancer Hospital & Institute, Sichuan Provincial Engineering Research Center for Tumor Organoids and Clinical Transformation, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[{"name":"Precision Radiation in Oncology Key Laboratory of Sichuan Province, Department of Experimental Research, Sichuan Cancer Hospital & Institute, Sichuan Provincial Engineering Research Center for Tumor Organoids and Clinical Transformation, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Liu","sequence":"additional","affiliation":[{"name":"Precision Radiation in Oncology Key Laboratory of Sichuan Province, Department of Experimental Research, Sichuan Cancer Hospital & Institute, Sichuan Provincial Engineering Research Center for Tumor Organoids and Clinical Transformation, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikun","family":"Luo","sequence":"additional","affiliation":[{"name":"Precision Radiation in Oncology Key Laboratory of Sichuan Province, Department of Experimental Research, Sichuan Cancer Hospital & Institute, Sichuan Provincial Engineering Research Center for Tumor Organoids and Clinical Transformation, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[{"name":"Precision Radiation in Oncology Key Laboratory of Sichuan Province, Department of Experimental Research, Sichuan Cancer Hospital & Institute, Sichuan Provincial Engineering Research Center for Tumor Organoids and Clinical Transformation, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefei","family":"Tian","sequence":"additional","affiliation":[{"name":"Precision Radiation in Oncology Key Laboratory of Sichuan Province, Department of Experimental Research, Sichuan Cancer Hospital & Institute, Sichuan Provincial Engineering Research Center for Tumor Organoids and Clinical Transformation, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]},{"name":"School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Huang","sequence":"additional","affiliation":[{"name":"Precision Radiation in Oncology Key Laboratory of Sichuan Province, Department of Experimental Research, Sichuan Cancer Hospital & Institute, Sichuan Provincial Engineering Research Center for Tumor Organoids and Clinical Transformation, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenni","family":"Xu","sequence":"additional","affiliation":[{"name":"Precision Radiation in Oncology Key Laboratory of Sichuan Province, Department of Experimental Research, Sichuan Cancer Hospital & Institute, Sichuan Provincial Engineering Research Center for Tumor Organoids and Clinical Transformation, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Lang","sequence":"additional","affiliation":[{"name":"Precision Radiation in Oncology Key Laboratory of Sichuan Province, Department of Experimental Research, Sichuan Cancer Hospital & Institute, Sichuan Provincial Engineering Research Center for Tumor Organoids and Clinical Transformation, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudan","family":"Lei","sequence":"additional","affiliation":[{"name":"Precision Radiation in Oncology Key Laboratory of Sichuan Province, Department of Experimental Research, Sichuan Cancer Hospital & Institute, Sichuan Provincial Engineering Research Center for Tumor Organoids and Clinical Transformation, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengqun","family":"Liu","sequence":"additional","affiliation":[{"name":"Precision Radiation in Oncology Key Laboratory of Sichuan Province, Department of Experimental Research, Sichuan Cancer Hospital & Institute, Sichuan Provincial Engineering Research Center for Tumor Organoids and Clinical Transformation, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.08.059","article-title":"Pathways of colorectal carcinogenesis","volume":"158","author":"Nguyen","year":"2020","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16812","article-title":"Toll-like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer","volume":"8","author":"Maitra","year":"2017","journal-title":"Oncotarget"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2022.04.016","article-title":"Rethinking healthy eating in light of the gut microbiome","volume":"30","author":"Armet","year":"2022","journal-title":"Cell Host and Microbe"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-00445-1","article-title":"Rising incidence of early-onset colorectal cancer \u2014 a call to action","volume":"18","author":"Akimoto","year":"2021","journal-title":"Nature Reviews Clinical Oncology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2024.101941","article-title":"Gut microbiota in colorectal cancer: from pathogenesis to clinic","volume":"72","author":"Fusco","year":"2024","journal-title":"Best Practice and Research Clinical Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2024.115420","article-title":"Butyrate: a potential mediator of obesity and microbiome via different mechanisms of actions","volume":"199","author":"Saban G\u00fcler","year":"2025","journal-title":"Food Research International"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1203\/01.pdr.0000250014.92242.f3","article-title":"Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier","volume":"61","author":"Peng","year":"2007","journal-title":"Pediatric Research"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.018","article-title":"The colonic crypt protects stem cells from microbiota-derived metabolites","volume":"165","author":"Kaiko","year":"2016","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2022.10.024","article-title":"Butyrate's role in human health and the current progress towards its clinical application to treat gastrointestinal disease","volume":"42","author":"Hodgkinson","year":"2023","journal-title":"Clinical Nutrition"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205563","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Advanced Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.948217","article-title":"Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer","volume":"10","author":"Pramanik","year":"2022","journal-title":"Frontiers in Chemistry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34974","article-title":"Recent histone deacetylase inhibitors in cancer therapy","volume":"129","author":"Parveen","year":"2023","journal-title":"Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/nu10060731","article-title":"Targeting histone deacetylases with natural and synthetic agents: an emerging anticancer strategy","volume":"10","author":"Singh","year":"2018","journal-title":"Nutrients"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115111","article-title":"Zinc-dependent histone deacetylases: potential therapeutic targets for arterial hypertension","volume":"202","author":"Kee","year":"2022","journal-title":"Biochemical Pharmacology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8797206","article-title":"HDAC inhibitors as epigenetic regulators of the immune system: impacts on cancer therapy and inflammatory diseases","volume":"2016","author":"Hull","year":"2016","journal-title":"BioMed Research International"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113825","article-title":"Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy","volume":"226","author":"Zhou","year":"2021","journal-title":"European Journal of Medicinal Chemistry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104920","article-title":"Unlocking the therapeutic potential of HDAC inhibitors in colorectal cancer: mechanisms, efficacy, and future perspectives","volume":"215","author":"Wen","year":"2025","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.15403\/jgld-5388","article-title":"Current applications of colorectal cancer organoids: a review","volume":"33","author":"Ban","year":"2024","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225677","article-title":"Development and characterization of a genetic mouse model of KRAS mutated colorectal cancer","volume":"20","author":"Maitra","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.16016\/j.1000-5404.201907198","article-title":"Potential capacities of different intestinal epithelial cell lines to form enteroids in 3D culture system: comparison and application","volume":"42","author":"Ou","year":"2020","journal-title":"Journal of Army Medical University"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010077","article-title":"HDAC inhibitor SAHA enhances antitumor immunity via the HDAC1\/JAK1\/FGL1 axis in lung adenocarcinoma","volume":"12","author":"Xu","year":"2024","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.16016\/j.2097-0927.202307077","article-title":"Comparison of 2 different mouse models of colorectal cancer and their application","volume":"46","author":"Feng","year":"2024","journal-title":"Journal of Army Medical University"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1537651","article-title":"Phase-dependent iron depletion differentially regulates the niche of intestinal stem cells in experimental colitis via ERK\/STAT3 signaling pathway","volume":"16","author":"Wang","year":"2025","journal-title":"Frontiers in Immunology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/path.6360","article-title":"Loss of Mist1 alters the characteristics of Paneth cells and impacts the function of intestinal stem cells in physiological conditions and after radiation injury","volume":"265","author":"Huang","year":"2025","journal-title":"Journal of Pathology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102822","article-title":"Butyrate reverses ferroptosis resistance in colorectal cancer by inducing c-Fos-dependent xCT suppression","volume":"65","author":"He","year":"2023","journal-title":"Redox Biology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1101\/gad.348226.120","article-title":"Genetic and biological hallmarks of colorectal cancer","volume":"35","author":"Li","year":"2021","journal-title":"Genes and Development"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S235575","article-title":"Sodium butyrate selectively kills cancer cells and inhibits migration in colorectal cancer by targeting thioredoxin-1","volume":"13","author":"Wang","year":"2020","journal-title":"OncoTargets and Therapy"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-07845-1","article-title":"Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network","volume":"21","author":"Xi","year":"2021","journal-title":"BMC Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201700844","article-title":"Sodium butyrate inhibits colorectal cancer cell migration by downregulating Bmi-1 through enhanced miR-200c expression","volume":"62","author":"Xu","year":"2018","journal-title":"Molecular Nutrition and Food Research"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-276","article-title":"Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation","volume":"9","author":"Yu","year":"2010","journal-title":"Molecular Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2013.10.028","article-title":"Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway","volume":"62","author":"Zuo","year":"2013","journal-title":"Food and Chemical Toxicology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7150\/jca.25324","article-title":"Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer","volume":"9","author":"Wu","year":"2018","journal-title":"Journal of Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.03.002","article-title":"Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity","volume":"33","author":"He","year":"2021","journal-title":"Cell Metabolism"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01375-4","article-title":"Drugging KRAS: current perspectives and state-of-art review","volume":"15","author":"Parikh","year":"2022","journal-title":"Journal of Hematology and Oncology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2024.13389","article-title":"KRAS inhibitors may prevent colorectal cancer metachronous metastasis by suppressing TGF-\u03b2 mediated epithelial-mesenchymal transition","volume":"31","author":"Guo","year":"2024","journal-title":"Molecular Medicine Reports"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.04.003","article-title":"Immunotherapy of colorectal cancer: challenges for therapeutic efficacy","volume":"76","author":"Ciardiello","year":"2019","journal-title":"Cancer Treatment Reviews"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00369","article-title":"Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer","volume":"11","author":"Picard","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17132129","article-title":"The role of organoids in advancing colorectal cancer research: insights and future directions","volume":"17","author":"Heydari","year":"2025","journal-title":"Cancers"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02374-y","article-title":"Establishing 3D organoid models from patient-derived conditionally reprogrammed cells to bridge preclinical and clinical insights in pancreatic cancer","volume":"24","author":"Kim","year":"2025","journal-title":"Molecular Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nature Reviews Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-025-00562-5","article-title":"NUCKS1 promotes invasion and metastasis of colorectal cancer by stabilizing HDAC2 and activating AKT","volume":"14","author":"Zhu","year":"2025","journal-title":"Oncogenesis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401964","article-title":"PJA2 suppresses colorectal cancer progression by controlling HDAC2 degradation and stability","volume":"12","author":"Chen","year":"2025","journal-title":"Advanced Science"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/bs.ai.2020.06.001","article-title":"Histone deacetylases as targets in autoimmune and autoinflammatory diseases","volume":"147","author":"Hamminger","year":"2020","journal-title":"Advances in Immunology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-019-0053-2","article-title":"Harnessing the HDAC\u2013histone deacetylase enzymes, inhibitors and how these can be utilized in tissue engineering","volume":"11","author":"Lawlor","year":"2019","journal-title":"International Journal of Oral Science"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1788434\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:45:02Z","timestamp":1779169502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1788434\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2026.1788434"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1788434","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1788434.s001","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"article-number":"1788434"}}